Ligand Pharmaceuticals (LGNDZ) Q3 2024 Earnings

Aug 6Confirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
0.62
0.88
1.14
1.4

Details

Expected EPS
1.0562
Actual EPS
1.4
Surprise EPS
0.34
Surprise Percent
+32.55%

Description

⁨Ligand Pharmaceuticals⁩ (⁦LGNDZ⁩) has reported earnings of ⁦1.4⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts